Page last updated: 2024-12-10

costunolide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators
FloraRankFlora DefinitionFamilyFamily Definition
Eremanthusgenus[no description available]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]
Eremanthusgenus[no description available]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]

Cross-References

ID SourceID
PubMed CID5281437
CHEMBL ID86416
CHEBI ID3900
SCHEMBL ID92714
MeSH IDM0043272
PubMed CID5367559
MeSH IDM0043272

Synonyms (47)

Synonym
HMS3269I17
AKOS015840065
(e,e)-6-alpha-hydroxygermacra-1(10),4,11(13)-trien-12-oic acid gamma-lactone
C09382
cyclodeca[b]furan-2(3h)-one, 3a,4,5,8,9,11a-hexahydro-6,10-dimethyl-3-methylene-, (3as,6e,10e,11ar)-
(3as,6e,10e,11ar)-6,10-dimethyl-3-methylene-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-2-one
(3as,6e,10e,11ar)-6,10-dimethyl-3-methylidene-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-2(3h)-one
CHEBI:3900 ,
(3as,6e,10e,11ar)-6,10-dimethyl-3-methylene-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-2(3h)-one
(3as,6e,10e)-3-methylene-6,10-dimethyl-2,3,3abeta,4,5,8,9,11aalpha-octahydrocyclodeca[b]furan-2-one
(e,e)-germacra-1(10),4,11(13)-trien-12-oic acid, 6-alpha-hydroxy-gamma-lactone
(10s,1r)-3,7-dimethyl-11-methylene-13-oxabicyclo[8.3.0]trideca-2,6-dien-12-one
(3as,6e,10e,11ar)-6,10-dimethyl-3-methylidene-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-2-one
CHEMBL86416 ,
melampolide
AKOS015969714
bdbm50411242
CS-1487
HY-N0036
SCHEMBL92714
(3as,6e,10e,11ar)-3a,4,5,8,9,11a-hexahydro-6,10-dimethyl-3-methylene-cyclodeca[b]furan-2(3h)-one
AC-28334
costunolide, >=97% (hplc)
NCGC00381718-02
mfcd00210262
HMS3677B19
costunolide,(s)
(3as,6e,10e,11ar)-6,10-dimethyl-3-methylene-3,3a,4,5,8,9-hexahydrocyclodeca[b]furan-2(11ah)-one
AS-17708
C2921
HMS3413B19
Q5175227
BRD-K26833429-001-01-0
EX-A5462
nsc 106404
costunlide
553-21-9
costus lactone
costunolide ,
costunolid
(6z,10z)-6,10-dimethyl-3-methylidene-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-2-one
BRD-A49888826-001-01-8
cyclodeca[b]furan-2(3h)-one, 3a,4,5,8,9,11a-hexahydro-6,10-dimethyl-3-methylene-, [3as-(3ar*,6e,10e,11as*)]-
(e,e)-6-.alpha.-hydroxygermacra-1(10),4,11(13)-trien-12-oic acid .gamma.-lactone
HRYLQFBHBWLLLL-GYIATTAWSA-N
6,10-dimethyl-3-methylene-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-2(3h)-one-, (3as,6e,10e,11ar)-
germacra-1(10),4,11(13)-trien-12-oic acid, 6.alpha.-hydroxy-, .gamma.-lactone, (e,e)-

Research Excerpts

Pharmacokinetics

Costunolide (Co) and dehydrocostuslactone (De) in blood samples in the positive ion mode, with diazepam as the internal standard substance. Study was to study the pharmacokinetic process of sesquiterpene lactones after the oral administration of Weichang'an pills.

ExcerptReferenceRelevance
"It was the first report for the study of pharmacokinetic profile of costunolide and dehydrocostuslactone in rat plasma after oral administration of RA extract."( Pharmacokinetic study on costunolide and dehydrocostuslactone after oral administration of traditional medicine Aucklandia lappa Decne. by LC/MS/MS.
Gao, W; Guo, H; Hu, X; Liu, C; Liu, Z; Qu, Z; Zhang, J, 2014
)
0.4
"A HPLC-MS/MS multiple-reaction monitoring (MRM) quantitative analysis was made to establish a determination method for drug concentrations of costunolide (Co) and dehydrocostuslactone (De) in blood samples in the positive ion mode, with diazepam as the internal standard substance, in order to study the pharmacokinetic process of sesquiterpene lactones costunolide and dehydrocostuslactone after the oral administration of Weichang'an pills, and provide an theoretical basis for further studies on the substance basis for the anti-diarrhea effect of Weichang'an pills."( [Pharmacokinetics study on costunolide and dehydrocostuslactone after administration of traditional Chinese medicine Weichang'an pills].
Chen, YL; Gao, WY; Jin, ZX; Qu, Z; Wang, L; Zhang, JZ, 2015
)
0.42

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" Based on the results, the oral bioavailability of BA in rats at 20 mg/kg is 15."( Determination of bakkenolide A in rat plasma using liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study.
Bao, Y; Chen, F; Chen, X; Dai, D; Li, J; Liu, S; Pei, L; Zheng, J, 2012
)
0.38
" The bioavailability of Cos was larger than that of Dehy; however, the clearance and the volume of distribution of Dehy were much larger than those of Cos."( Study on the pharmacokinetics and metabolism of costunolide and dehydrocostus lactone in rats by HPLC-UV and UPLC-Q-TOF/MS.
Gu, X; Guo, X; Peng, Z; Wang, Y; Yan, C, 2014
)
0.4

Dosage Studied

ExcerptRelevanceReference
" These rats were fed the diet containing 200 ppm of each test chemical for 5 weeks, starting 1 week before the first dosing of AOM."( Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
Hara, A; Kawamori, T; Mori, H; Tanaka, T; Yamahara, J, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (6)

RoleDescription
anthelminthic drugSubstance intended to kill parasitic worms (helminths).
antiinfective agentA substance used in the prophylaxis or therapy of infectious diseases.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
antiparasitic agentA substance used to treat or prevent parasitic infections.
antiviral drugA substance used in the prophylaxis or therapy of virus diseases.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
germacranolideA sesquiterpene lactone based on germacrane skeleton.
heterobicyclic compoundA bicyclic compound in which at least one of the rings contains at least one skeletal heteroatom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
costunolide biosynthesis914
3u03B2-hydroxysesquiterpene lactone biosynthesis06

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
PPM1D proteinHomo sapiens (human)Potency26.21230.00529.466132.9993AID1347411
Interferon betaHomo sapiens (human)Potency26.21230.00339.158239.8107AID1347411
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transcriptional activator MybGallus gallus (chicken)IC50 (µMol)30.67510.62522.76989.5499AID746038
UDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12IC50 (µMol)50.00000.10004.21698.8000AID276339
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Taste receptor type 2 member 46Homo sapiens (human)EC50 (µMol)8.60000.00493.09838.6000AID1619395
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Prostaglandin G/H synthase 2Homo sapiens (human)IC60 (µMol)6.90006.90006.90006.9000AID403340
Transcription factor p65Homo sapiens (human)IC100 (µMol)50.00005.00009.000010.0000AID262798
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (170)

Processvia Protein(s)Taxonomy
regulation of gene expressionTranscriptional activator MybGallus gallus (chicken)
mitotic cell cycleTranscriptional activator MybGallus gallus (chicken)
positive regulation of transcription by RNA polymerase IITranscriptional activator MybGallus gallus (chicken)
peptidoglycan biosynthetic processUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
regulation of cell shapeUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
peptidoglycan biosynthetic processUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
UDP-N-acetylgalactosamine biosynthetic processUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
cell divisionUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
cell wall organizationUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 2Homo sapiens (human)
embryo implantationProstaglandin G/H synthase 2Homo sapiens (human)
learningProstaglandin G/H synthase 2Homo sapiens (human)
memoryProstaglandin G/H synthase 2Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell population proliferationProstaglandin G/H synthase 2Homo sapiens (human)
response to xenobiotic stimulusProstaglandin G/H synthase 2Homo sapiens (human)
response to nematodeProstaglandin G/H synthase 2Homo sapiens (human)
response to fructoseProstaglandin G/H synthase 2Homo sapiens (human)
response to manganese ionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 2Homo sapiens (human)
bone mineralizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fever generationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic plasticityProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of synaptic transmission, dopaminergicProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin secretionProstaglandin G/H synthase 2Homo sapiens (human)
response to estradiolProstaglandin G/H synthase 2Homo sapiens (human)
response to lipopolysaccharideProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationProstaglandin G/H synthase 2Homo sapiens (human)
response to vitamin DProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to heatProstaglandin G/H synthase 2Homo sapiens (human)
response to tumor necrosis factorProstaglandin G/H synthase 2Homo sapiens (human)
maintenance of blood-brain barrierProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of protein import into nucleusProstaglandin G/H synthase 2Homo sapiens (human)
hair cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of apoptotic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vasoconstrictionProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
decidualizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle cell proliferationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of inflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
response to glucocorticoidProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of calcium ion transportProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicProstaglandin G/H synthase 2Homo sapiens (human)
response to fatty acidProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to mechanical stimulusProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to lead ionProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to ATPProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to hypoxiaProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to non-ionic osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to fluid shear stressProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of transforming growth factor beta productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fibroblast growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of platelet-derived growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of neuroinflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to homocysteineProstaglandin G/H synthase 2Homo sapiens (human)
response to angiotensinProstaglandin G/H synthase 2Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of bitter tasteTaste receptor type 2 member 46Homo sapiens (human)
G protein-coupled receptor signaling pathwayTaste receptor type 2 member 46Homo sapiens (human)
positive regulation of interleukin-1 beta productionTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-6 productionTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-8 productionTranscription factor p65Homo sapiens (human)
positive regulation of amyloid-beta formationTranscription factor p65Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activityTranscription factor p65Homo sapiens (human)
nucleotide-binding oligomerization domain containing 2 signaling pathwayTranscription factor p65Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITranscription factor p65Homo sapiens (human)
liver developmentTranscription factor p65Homo sapiens (human)
hair follicle developmentTranscription factor p65Homo sapiens (human)
defense response to tumor cellTranscription factor p65Homo sapiens (human)
response to ischemiaTranscription factor p65Homo sapiens (human)
acetaldehyde metabolic processTranscription factor p65Homo sapiens (human)
chromatin organizationTranscription factor p65Homo sapiens (human)
DNA-templated transcriptionTranscription factor p65Homo sapiens (human)
regulation of DNA-templated transcriptionTranscription factor p65Homo sapiens (human)
regulation of transcription by RNA polymerase IITranscription factor p65Homo sapiens (human)
inflammatory responseTranscription factor p65Homo sapiens (human)
cellular defense responseTranscription factor p65Homo sapiens (human)
neuropeptide signaling pathwayTranscription factor p65Homo sapiens (human)
canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
positive regulation of cell population proliferationTranscription factor p65Homo sapiens (human)
response to xenobiotic stimulusTranscription factor p65Homo sapiens (human)
animal organ morphogenesisTranscription factor p65Homo sapiens (human)
response to UV-BTranscription factor p65Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionTranscription factor p65Homo sapiens (human)
positive regulation of gene expressionTranscription factor p65Homo sapiens (human)
positive regulation of Schwann cell differentiationTranscription factor p65Homo sapiens (human)
negative regulation of angiogenesisTranscription factor p65Homo sapiens (human)
cytokine-mediated signaling pathwayTranscription factor p65Homo sapiens (human)
protein catabolic processTranscription factor p65Homo sapiens (human)
response to muramyl dipeptideTranscription factor p65Homo sapiens (human)
response to progesteroneTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-12 productionTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-6 productionTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-8 productionTranscription factor p65Homo sapiens (human)
response to insulinTranscription factor p65Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayTranscription factor p65Homo sapiens (human)
negative regulation of protein sumoylationTranscription factor p65Homo sapiens (human)
response to cobalaminTranscription factor p65Homo sapiens (human)
toll-like receptor 4 signaling pathwayTranscription factor p65Homo sapiens (human)
intracellular signal transductionTranscription factor p65Homo sapiens (human)
cellular response to hepatocyte growth factor stimulusTranscription factor p65Homo sapiens (human)
response to muscle stretchTranscription factor p65Homo sapiens (human)
non-canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
vascular endothelial growth factor signaling pathwayTranscription factor p65Homo sapiens (human)
prolactin signaling pathwayTranscription factor p65Homo sapiens (human)
negative regulation of protein catabolic processTranscription factor p65Homo sapiens (human)
negative regulation of apoptotic processTranscription factor p65Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
response to amino acidTranscription factor p65Homo sapiens (human)
negative regulation of DNA-templated transcriptionTranscription factor p65Homo sapiens (human)
positive regulation of DNA-templated transcriptionTranscription factor p65Homo sapiens (human)
positive regulation of transcription by RNA polymerase IITranscription factor p65Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTranscription factor p65Homo sapiens (human)
regulation of inflammatory responseTranscription factor p65Homo sapiens (human)
positive regulation of T cell receptor signaling pathwayTranscription factor p65Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activityTranscription factor p65Homo sapiens (human)
response to cAMPTranscription factor p65Homo sapiens (human)
defense response to virusTranscription factor p65Homo sapiens (human)
cellular response to hydrogen peroxideTranscription factor p65Homo sapiens (human)
interleukin-1-mediated signaling pathwayTranscription factor p65Homo sapiens (human)
response to interleukin-1Transcription factor p65Homo sapiens (human)
cellular response to lipopolysaccharideTranscription factor p65Homo sapiens (human)
cellular response to lipoteichoic acidTranscription factor p65Homo sapiens (human)
cellular response to peptidoglycanTranscription factor p65Homo sapiens (human)
cellular response to nicotineTranscription factor p65Homo sapiens (human)
cellular response to interleukin-1Transcription factor p65Homo sapiens (human)
cellular response to interleukin-6Transcription factor p65Homo sapiens (human)
cellular response to tumor necrosis factorTranscription factor p65Homo sapiens (human)
postsynapse to nucleus signaling pathwayTranscription factor p65Homo sapiens (human)
antiviral innate immune responseTranscription factor p65Homo sapiens (human)
negative regulation of non-canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
negative regulation of miRNA transcriptionTranscription factor p65Homo sapiens (human)
positive regulation of miRNA transcriptionTranscription factor p65Homo sapiens (human)
cellular response to angiotensinTranscription factor p65Homo sapiens (human)
positive regulation of leukocyte adhesion to vascular endothelial cellTranscription factor p65Homo sapiens (human)
positive regulation of miRNA metabolic processTranscription factor p65Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathwayTranscription factor p65Homo sapiens (human)
cellular response to stressTranscription factor p65Homo sapiens (human)
response to cytokineTranscription factor p65Homo sapiens (human)
innate immune responseTranscription factor p65Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (39)

Processvia Protein(s)Taxonomy
protein bindingTranscriptional activator MybGallus gallus (chicken)
DNA-binding transcription factor activity, RNA polymerase II-specificTranscriptional activator MybGallus gallus (chicken)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTranscriptional activator MybGallus gallus (chicken)
UDP-N-acetylglucosamine 1-carboxyvinyltransferase activityUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
transferase activityUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
peroxidase activityProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 2Homo sapiens (human)
protein bindingProstaglandin G/H synthase 2Homo sapiens (human)
enzyme bindingProstaglandin G/H synthase 2Homo sapiens (human)
heme bindingProstaglandin G/H synthase 2Homo sapiens (human)
protein homodimerization activityProstaglandin G/H synthase 2Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 2Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 2Homo sapiens (human)
G protein-coupled receptor activityTaste receptor type 2 member 46Homo sapiens (human)
bitter taste receptor activityTaste receptor type 2 member 46Homo sapiens (human)
transcription cis-regulatory region bindingTranscription factor p65Homo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingTranscription factor p65Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTranscription factor p65Homo sapiens (human)
RNA polymerase II core promoter sequence-specific DNA bindingTranscription factor p65Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificTranscription factor p65Homo sapiens (human)
transcription coactivator bindingTranscription factor p65Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificTranscription factor p65Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificTranscription factor p65Homo sapiens (human)
DNA bindingTranscription factor p65Homo sapiens (human)
chromatin bindingTranscription factor p65Homo sapiens (human)
DNA-binding transcription factor activityTranscription factor p65Homo sapiens (human)
protein bindingTranscription factor p65Homo sapiens (human)
enzyme bindingTranscription factor p65Homo sapiens (human)
protein kinase bindingTranscription factor p65Homo sapiens (human)
chromatin DNA bindingTranscription factor p65Homo sapiens (human)
ubiquitin protein ligase bindingTranscription factor p65Homo sapiens (human)
peptide bindingTranscription factor p65Homo sapiens (human)
phosphate ion bindingTranscription factor p65Homo sapiens (human)
identical protein bindingTranscription factor p65Homo sapiens (human)
protein homodimerization activityTranscription factor p65Homo sapiens (human)
actinin bindingTranscription factor p65Homo sapiens (human)
histone deacetylase bindingTranscription factor p65Homo sapiens (human)
NF-kappaB bindingTranscription factor p65Homo sapiens (human)
ankyrin repeat bindingTranscription factor p65Homo sapiens (human)
general transcription initiation factor bindingTranscription factor p65Homo sapiens (human)
DNA-binding transcription factor bindingTranscription factor p65Homo sapiens (human)
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (23)

Processvia Protein(s)Taxonomy
nucleoplasmTranscriptional activator MybGallus gallus (chicken)
nucleusTranscriptional activator MybGallus gallus (chicken)
cytoplasmUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
cytosolUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
nuclear inner membraneProstaglandin G/H synthase 2Homo sapiens (human)
nuclear outer membraneProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulumProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum lumenProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 2Homo sapiens (human)
caveolaProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
protein-containing complexProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
plasma membraneTaste receptor type 2 member 46Homo sapiens (human)
membraneTaste receptor type 2 member 46Homo sapiens (human)
ciliary membraneTaste receptor type 2 member 46Homo sapiens (human)
membraneTaste receptor type 2 member 46Homo sapiens (human)
nucleolusTranscription factor p65Homo sapiens (human)
nucleusTranscription factor p65Homo sapiens (human)
glutamatergic synapseTranscription factor p65Homo sapiens (human)
nucleusTranscription factor p65Homo sapiens (human)
nucleoplasmTranscription factor p65Homo sapiens (human)
cytoplasmTranscription factor p65Homo sapiens (human)
cytosolTranscription factor p65Homo sapiens (human)
NF-kappaB p50/p65 complexTranscription factor p65Homo sapiens (human)
NF-kappaB complexTranscription factor p65Homo sapiens (human)
chromatinTranscription factor p65Homo sapiens (human)
transcription regulator complexTranscription factor p65Homo sapiens (human)
cytoplasmTranscription factor p65Homo sapiens (human)
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (75)

Assay IDTitleYearJournalArticle
AID269423Cytotoxicity against human K562 cell line2006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Synthesis of 13-amino costunolide derivatives as anticancer agents.
AID1240842Cytotoxicity against human HL60/A cells2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
Syntheses and Biological Evaluation of Costunolide, Parthenolide, and Their Fluorinated Analogues.
AID269432Safety index, IC50 for K562/IC50 for NIH3T32006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Synthesis of 13-amino costunolide derivatives as anticancer agents.
AID170007Effect of compound (25 mg/kg) on Blood Ethanol level in Ethanol loaded rats after 1 hr1999Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
Preventive effect of sesquiterpenes from bay leaf on blood ethanol elevation in ethanol-loaded rat: structure requirement and suppression of gastric emptying.
AID276340Inhibition of Pseudomonas aeruginosa PAO1293 MurA in presence of UNAG2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA.
AID387024Cytotoxicity against human KB cells2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Use of self-organizing maps and molecular descriptors to predict the cytotoxic activity of sesquiterpene lactones.
AID269425Cytotoxicity against human DU145 cell line2006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Synthesis of 13-amino costunolide derivatives as anticancer agents.
AID332895Vasorelaxant activity in rabbit aorta assessed as inhibition of KCl-induced contraction
AID276341Inhibition of Escherichia coli K12 Mur A C115D at 50 uM in presence of UNAG2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA.
AID269420Cytotoxicity against human HBL100 cell line2006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Synthesis of 13-amino costunolide derivatives as anticancer agents.
AID356397Cytotoxicity against human HeLa cells after 48 hrs by MTT assay2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID183543Effect of compound (25 mg/kg) on Gastric emptying in Ethanol loaded rats after 30 minutes1999Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
Preventive effect of sesquiterpenes from bay leaf on blood ethanol elevation in ethanol-loaded rat: structure requirement and suppression of gastric emptying.
AID269428Cytotoxicity against mouse NIH3T3 cell line2006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Synthesis of 13-amino costunolide derivatives as anticancer agents.
AID355139Inhibition of nitric oxides synthase in mouse J774.1 cells assessed as inhibition of LPS-induced NO release at 100 ug/mL after 48 hrs by Griess assay relative to control1996Journal of natural products, Dec, Volume: 59, Issue:12
Syringin 4-O-beta-glucoside, a new phenylpropanoid glycoside, and costunolide, a nitric oxide synthase inhibitor, from the stem bark of Magnolia sieboldii.
AID310936Cytotoxicity against human KB cells2007Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8
Quantitative structure-activity relationship of sesquiterpene lactones with cytotoxic activity.
AID191285Effect of compound (25 mg/kg) on Serum glucose level in glucose loaded rats after 2 hr1999Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
Preventive effect of sesquiterpenes from bay leaf on blood ethanol elevation in ethanol-loaded rat: structure requirement and suppression of gastric emptying.
AID170010Effect of compound (50 mg/kg) on Blood Ethanol level in Ethanol loaded rats after 1 hr1999Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
Preventive effect of sesquiterpenes from bay leaf on blood ethanol elevation in ethanol-loaded rat: structure requirement and suppression of gastric emptying.
AID1240839Cytotoxicity against human KG1a cells2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
Syntheses and Biological Evaluation of Costunolide, Parthenolide, and Their Fluorinated Analogues.
AID183546Effect of compound (50 mg/kg) on Gastric emptying time in Ethanol loaded rats after 30 minutes1999Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
Preventive effect of sesquiterpenes from bay leaf on blood ethanol elevation in ethanol-loaded rat: structure requirement and suppression of gastric emptying.
AID170011Effect of compound (50 mg/kg) on Blood Ethanol level in Ethanol loaded rats after 2 hr1999Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
Preventive effect of sesquiterpenes from bay leaf on blood ethanol elevation in ethanol-loaded rat: structure requirement and suppression of gastric emptying.
AID356399Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID269424Cytotoxicity against human PA1 cell line2006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Synthesis of 13-amino costunolide derivatives as anticancer agents.
AID746038Inhibition of c-Myb-induced mim-1 gene expression in doxycyclin-treated chicken HD11 cells after 24 hrs by GFP assay2013European journal of medicinal chemistry, May, Volume: 63Natural sesquiterpene lactones as inhibitors of Myb-dependent gene expression: structure-activity relationships.
AID269426Cytotoxicity against human KB cell line2006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Synthesis of 13-amino costunolide derivatives as anticancer agents.
AID269434Safety index, IC50 for DU145/IC50 for NIH3T32006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Synthesis of 13-amino costunolide derivatives as anticancer agents.
AID403340Inhibition of COX22005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID170008Effect of compound (25 mg/kg) on Blood Ethanol level in Ethanol loaded rats after 2 hr1999Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
Preventive effect of sesquiterpenes from bay leaf on blood ethanol elevation in ethanol-loaded rat: structure requirement and suppression of gastric emptying.
AID269431Safety index, IC50 for MiaPaca2/IC50 for NIH3T32006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Synthesis of 13-amino costunolide derivatives as anticancer agents.
AID713359Cytotoxicity against human leukemia stem/progenitor cells assessed as viable CD34+ cells at 10 uM after 18 hrs by annexin-V labeling-based flow cytometry2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells.
AID191289Effect of compound (50 mg/kg) on Serum glucose level in glucose loaded rats after 30 minutes1999Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
Preventive effect of sesquiterpenes from bay leaf on blood ethanol elevation in ethanol-loaded rat: structure requirement and suppression of gastric emptying.
AID356407Antibacterial activity against Escherichia coli2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID262798Inhibition of NF-kappaB DNA binding by EMSA2006Journal of medicinal chemistry, Apr-06, Volume: 49, Issue:7
Development of a structural model for NF-kappaB inhibition of sesquiterpene lactones using self-organizing neural networks.
AID356398Cytotoxicity against human OVCAR-3 cells after 48 hrs by MTT assay2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID191287Effect of compound (50 mg/kg) on Serum glucose level in glucose loaded rats after 1 hr1999Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
Preventive effect of sesquiterpenes from bay leaf on blood ethanol elevation in ethanol-loaded rat: structure requirement and suppression of gastric emptying.
AID191286Effect of compound (25 mg/kg) on Serum glucose level in glucose loaded rats after 30 minutes1999Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
Preventive effect of sesquiterpenes from bay leaf on blood ethanol elevation in ethanol-loaded rat: structure requirement and suppression of gastric emptying.
AID355141Cytotoxicity against mouse J774.1 cells assessed as cell viability after 48 hrs by MTT assay1996Journal of natural products, Dec, Volume: 59, Issue:12
Syringin 4-O-beta-glucoside, a new phenylpropanoid glycoside, and costunolide, a nitric oxide synthase inhibitor, from the stem bark of Magnolia sieboldii.
AID269436Safety index, IC50 for SW620/IC50 for NIH3T32006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Synthesis of 13-amino costunolide derivatives as anticancer agents.
AID1240840Cytotoxicity against rat C6 cells2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
Syntheses and Biological Evaluation of Costunolide, Parthenolide, and Their Fluorinated Analogues.
AID269435Safety index, IC50 for KB/IC50 for NIH3T32006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Synthesis of 13-amino costunolide derivatives as anticancer agents.
AID183545Effect of compound (50 mg/kg) on Gastric emptying in Ethanol loaded rats after 30 minutes1999Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
Preventive effect of sesquiterpenes from bay leaf on blood ethanol elevation in ethanol-loaded rat: structure requirement and suppression of gastric emptying.
AID642415Estrogenic activity at ERalpha in human MVLN cells at 20 ug/mL after 24 hrs by luciferase reporter gene assay relative to E22012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Discovery of estrogen receptor α modulators from natural compounds in Si-Wu-Tang series decoctions using estrogen-responsive MCF-7 breast cancer cells.
AID269430Safety index, IC50 for A549/IC50 for NIH3T32006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Synthesis of 13-amino costunolide derivatives as anticancer agents.
AID356406Antibacterial activity against Enterococcus faecalis2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID170012Effect of compound (50 mg/kg) on Blood Ethanol level in Ethanol loaded rats after 30 minutes1999Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
Preventive effect of sesquiterpenes from bay leaf on blood ethanol elevation in ethanol-loaded rat: structure requirement and suppression of gastric emptying.
AID713583Cytotoxicity against human HL60/A cells after 18 hrs by annexin-V labeling-based flow cytometry2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells.
AID642414Estrogenic activity at ERalpha in human MVLN cells at 100 ug/mL after 24 hrs by luciferase reporter gene assay relative to E22012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Discovery of estrogen receptor α modulators from natural compounds in Si-Wu-Tang series decoctions using estrogen-responsive MCF-7 breast cancer cells.
AID356405Antibacterial activity against methicillin-resistant Staphylococcus aureus2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID269421Cytotoxicity against human A549 cell line2006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Synthesis of 13-amino costunolide derivatives as anticancer agents.
AID1722057Inhibition of NLRP3 inflammasome in mouse J774.A1 cells assessed as reduction in LPS-induced IL-1beta release at 1 to 10 uM2020Bioorganic & medicinal chemistry letters, 09-01, Volume: 30, Issue:17
Synthesis and biological evaluation of parthenolide derivatives with reduced toxicity as potential inhibitors of the NLRP3 inflammasome.
AID355140Inhibition of nitric oxides synthase in mouse J774.1 cells assessed as inhibition of LPS-induced NO release at 1 ug/mL after 48 hrs by Griess assay relative to control1996Journal of natural products, Dec, Volume: 59, Issue:12
Syringin 4-O-beta-glucoside, a new phenylpropanoid glycoside, and costunolide, a nitric oxide synthase inhibitor, from the stem bark of Magnolia sieboldii.
AID269433Safety index, IC50 for PA1/IC50 for NIH3T32006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Synthesis of 13-amino costunolide derivatives as anticancer agents.
AID191284Effect of compound (25 mg/kg) on Serum glucose level in glucose loaded rats after 1 hr1999Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
Preventive effect of sesquiterpenes from bay leaf on blood ethanol elevation in ethanol-loaded rat: structure requirement and suppression of gastric emptying.
AID1754175Antiinflammatory activity in mouse RAW264.7 assessed as inhibition of LPS-induced NO production preincubated for 30 mins followed by LPS stimulation measured after 24 hrs by Griess reagent based assay2021Journal of natural products, 05-28, Volume: 84, Issue:5
Tulipiferamide A, an Alkamide from
AID1722058Inhibition of NLRP3 inflammasome in human primary glial cells assessed as reduction in LPS-induced IL-1beta release at 1 to 10 uM2020Bioorganic & medicinal chemistry letters, 09-01, Volume: 30, Issue:17
Synthesis and biological evaluation of parthenolide derivatives with reduced toxicity as potential inhibitors of the NLRP3 inflammasome.
AID276339Inhibition of Escherichia coli K12 Mur A in presence of UNAG2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA.
AID713360Cytotoxicity against human leukemia stem/progenitor cells assessed as viable CD34+ cells at 5 uM after 18 hrs by annexin-V labeling-based flow cytometry2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells.
AID269427Cytotoxicity against human SW620 cell line2006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Synthesis of 13-amino costunolide derivatives as anticancer agents.
AID746037Cytotoxicity against chicken HD11 cells assessed as cell viability after 24 hrs by MTS assay2013European journal of medicinal chemistry, May, Volume: 63Natural sesquiterpene lactones as inhibitors of Myb-dependent gene expression: structure-activity relationships.
AID713362Cytotoxicity against human leukemia stem/progenitor cells assessed as cell viability at 5 uM after 18 hrs by annexin-V labeling-based flow cytometry2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells.
AID191288Effect of compound (50 mg/kg) on Serum glucose level in glucose loaded rats after 2 hr1999Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
Preventive effect of sesquiterpenes from bay leaf on blood ethanol elevation in ethanol-loaded rat: structure requirement and suppression of gastric emptying.
AID170009Effect of compound (25 mg/kg) on Blood Ethanol level in Ethanol loaded rats after 30 minutes1999Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
Preventive effect of sesquiterpenes from bay leaf on blood ethanol elevation in ethanol-loaded rat: structure requirement and suppression of gastric emptying.
AID356402Antibacterial activity against Staphylococcus aureus2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID183544Effect of compound (25 mg/kg) on Gastric emptying time in Ethanol loaded rats after 30 minutes1999Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
Preventive effect of sesquiterpenes from bay leaf on blood ethanol elevation in ethanol-loaded rat: structure requirement and suppression of gastric emptying.
AID269429Safety index, IC50 for HBL100/IC50 for NIH3T32006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Synthesis of 13-amino costunolide derivatives as anticancer agents.
AID713361Cytotoxicity against human leukemia stem/progenitor cells assessed as cell viability at 10 uM after 18 hrs by annexin-V labeling-based flow cytometry2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells.
AID713584Cytotoxicity against human HL60 cells after 18 hrs by annexin-V labeling-based flow cytometry2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells.
AID269422Cytotoxicity against human MiaPaca2 cell line2006Bioorganic & medicinal chemistry letters, Aug-15, Volume: 16, Issue:16
Synthesis of 13-amino costunolide derivatives as anticancer agents.
AID1240841Cytotoxicity against human HL60 cells2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
Syntheses and Biological Evaluation of Costunolide, Parthenolide, and Their Fluorinated Analogues.
AID356400Antibacterial activity against vancomycin-resistant Enterococcus CKU-172003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (193)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (1.55)18.7374
1990's12 (6.22)18.2507
2000's40 (20.73)29.6817
2010's88 (45.60)24.3611
2020's50 (25.91)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.70 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index47.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Reviews4 (2.20%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies1 (0.55%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
Other177 (97.25%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]